Announcement on Changing the Independent Financial Advisor for Continuous Supervision
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Changing the Independent Financial Advisor for Continuous Supervision
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-changing-the-independent-financial-advisor-for-continuous-supervision-1
Release
Zhuzhou Qianjin Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhuzhou Qianjin Pharmaceutical
- Announcement on Profit and Loss during Transition Period of Underlying Assets Related to the Company's Issuance of Shares and Payment of Cash to Purchase Assets and Related Party Transactions
- Announcement on Outline of the Q3 2025 Performance Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Main Operating Data for Q3 2025
Later from Zhuzhou Qianjin Pharmaceutical
- Announcement on Resolutions of the 15th Meeting of the 11th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Approval of Buoxue Yimu Pill as a National Protected Traditional Chinese Medicine Variety
- Announcement on Resignation of Director and Election of Employee Director
- Announcement on Preliminary Earnings Estimate for 2025
Follow Zhuzhou Qianjin Pharmaceutical into a list and get an email when it puts out news.
Follow Zhuzhou Qianjin Pharmaceutical